Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Muscle Function After Exacerbations of COPD to Limit Its Impact on Physical Activity Decline

NCT05233137 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT05233137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05233137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Muscle Function After Exacerbations of COPD to Limit Its Impact on Physical Activity Decline
Lead sponsor
KU Leuven
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2022
Completion date
January 14, 2025
Enrollment
86 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation